is semaglutide safe for high blood pressure Why Your Cardiologist May Prescribe (Wegovy) | News Users of Zepbound or Mounjaro

Email us: [email protected]

DESCRIPTION TABLE OF CONTENTS METHODOLOGY DOWNLOAD PDF GLP-1 Agonists Market by Product (Ozempic, Wegovy, Mounjaro), Molecule (semaglutide, tirzepatide), Type (Patented, Biosimilars), Format (Single dose, Multi-dose, Tablets), ROA (SC, Oral), Indication (Diabetes, Obesity) - Global Forecast to 2033 USD 170.75 BN MARKET SIZE, 2033 OVERVIEW Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis The global GLP-1 agonists market is expected to reach USD 170.75 billion in 2033 from USD 64.42 billion in 2025 at a CAGR of 13.0% during the forecast period

Heart rate increases were noted, depending on the dose

While work continues on solid oral forms of GLP-1s, the timeline and scale of impact remain uncertain

Your provider chooses which one and at what dose based on your labs, health history, and goals

Liraglutide decreases carotid intima-media thickness in patients with type 2 diabetes: 8-month prospective pilot study